Cargando…

Association Between Lipophilic Beta-Blockers and Depression in Diabetic Patients on Chronic Dialysis

BACKGROUND: Depression is associated with lower quality of life and increased risk of mortality. The prevalence of depression in chronic dialysis patients, as well as in patients with diabetes, is more than 20%. It is debated whether use of beta-blockers increases the risk of depression. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lengton, Robin, W Schouten, Robbert, Nadort, Els, van Rossum, Elisabeth FC, Dekker, Friedo W, Siegert, Carl EH, Hoogeveen, Ellen K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434677/ https://www.ncbi.nlm.nih.gov/pubmed/36061232 http://dx.doi.org/10.1177/11795514221119446

Ejemplares similares

The (cost) effectiveness of guided internet-based self-help CBT for dialysis patients with symptoms of depression: study protocol of a randomised controlled trial
por: Nadort, Els, et al.
Publicado: (2019)

Dialysis withdrawal and symptoms of anxiety and depression: a prospective cohort study
por: El-Magd, Essam S., et al.
Publicado: (2023)

Dimensions of Depressive Symptoms and Their Association With Mortality, Hospitalization, and Quality of Life in Dialysis Patients: A Cohort Study
por: Schouten, Robbert W., et al.
Publicado: (2019)

Depression, anxiety and quality of life of hemodialysis patients before and during the COVID-19 pandemic
por: Nadort, Els, et al.
Publicado: (2022)

Effect of residual kidney function and dialysis adequacy on chronic pruritus in dialysis patients
por: Lengton, Robin, et al.
Publicado: (2022)

Neuropsychiatric Consequences of Lipophilic Beta-Blockers
por: Cojocariu, Sabina Alexandra, et al.
Publicado: (2021)

Dyslipidemia and risk of renal replacement therapy or death in incident pre-dialysis patients
por: Voskamp, Pauline W. M., et al.
Publicado: (2018)

Obesity and risk of death or dialysis in younger and older patients on specialized pre-dialysis care
por: Hoogeveen, Ellen K., et al.
Publicado: (2017)

Validation of Two Screening Tools for Anxiety in Hemodialysis Patients
por: Nadort, Els, et al.
Publicado: (2022)

Itching in dialysis patients: impact on health-related quality of life and interactions with sleep problems and psychological symptoms—results from the RENINE/PROMs registry
por: van der Willik, Esmee M, et al.
Publicado: (2022)

Ethnic Differences in the Association of Depressive Symptoms with Clinical Outcome in Dialysis Patients
por: Schouten, Robbert W., et al.
Publicado: (2019)

Lower body mass index and mortality in older adults starting dialysis
por: Polinder-Bos, Harmke A., et al.
Publicado: (2018)

Publisher Correction: Lower body mass index and mortality in older adults starting dialysis
por: Polinder-Bos, Harmke A., et al.
Publicado: (2018)

Variation in glucocorticoid sensitivity and the relation with obesity
por: Lengton, Robin, et al.
Publicado: (2021)

Predicting Mortality in Patients with Diabetes Starting Dialysis
por: van Diepen, Merel, et al.
Publicado: (2014)

Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis
por: Esmeijer, K., et al.
Publicado: (2019)

Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients
por: Nacak, Hakan, et al.
Publicado: (2014)

Mortality after amputation in dialysis patients is high but not modified by diabetes status
por: Schroijen, Marielle A, et al.
Publicado: (2019)

Candidate Gene Analysis of Mortality in Dialysis Patients
por: Rothuizen, Tonia C., et al.
Publicado: (2015)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Association of Statin and Its Lipophilicity With Cardiovascular Events in Patients Receiving Chronic Dialysis
por: Wang, Shih‐Wei, et al.
Publicado: (2019)

Effect of Erythropoiesis-Stimulating Agents on Blood Pressure in Pre-Dialysis Patients
por: Suttorp, Marit M., et al.
Publicado: (2013)

Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis
por: Lin, Ting-Tse, et al.
Publicado: (2015)

Pre-dialysis patients' perceived autonomy, self-esteem and labor participation: associations with illness perceptions and treatment perceptions. A cross-sectional study
por: Jansen, Daphne L, et al.
Publicado: (2010)

Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
por: Suttorp, Marit M, et al.
Publicado: (2013)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Serum Potassium and Mortality Risk in Hemodialysis Patients: A Cohort Study
por: de Rooij, Esther N.M., et al.
Publicado: (2021)

Lipid Levels and Renal Function Decline in Pre-Dialysis Patients
por: de Goeij, Moniek C.M., et al.
Publicado: (2015)

Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition
por: Schroijen, Marielle A, et al.
Publicado: (2011)

Vitamin K antagonist use and renal function in pre-dialysis patients
por: Voskamp, Pauline WM, et al.
Publicado: (2018)

Body-fat indicators and kidney function decline in older post-myocardial infarction patients: The Alpha Omega Cohort Study
por: Esmeijer, Kevin, et al.
Publicado: (2017)

Perioperative use of beta-blockers
por: Priebe, Hans-Joachim
Publicado: (2009)

Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014)

Course of Symptoms and Health-Related Quality of Life during Specialized Pre-Dialysis Care
por: de Goeij, Moniek C. M., et al.
Publicado: (2014)

Response to: A myth of ophthalmic beta-blockers therapy
por: Wolfs, Roger C. W.
Publicado: (2009)

Effect of glomerular filtration rate at dialysis initiation on survival in patients with advanced chronic kidney disease: what is the effect of lead-time bias?
por: Janmaat, Cynthia J, et al.
Publicado: (2017)

Predicting mortality after start of long-term dialysis–International validation of one- and two-year prediction models
por: Haapio, Mikko, et al.
Publicado: (2023)

Von Willebrand factor, ADAMTS13 and mortality in dialysis patients
por: Ocak, Gurbey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l3p2ehdtie20a862ob1hdafdbt